Your browser doesn't support javascript.
loading
Targeted siRNA nanocarrier: a platform technology for cancer treatment.
Bäumer, Nicole; Tiemann, Jessica; Scheller, Annika; Meyer, Theresa; Wittmann, Lisa; Suburu, Matias Ezequiel Gutierrez; Greune, Lilo; Peipp, Matthias; Kellmann, Neele; Gumnior, Annika; Brand, Caroline; Hartmann, Wolfgang; Rossig, Claudia; Müller-Tidow, Carsten; Neri, Dario; Strassert, Cristian A; Rüter, Christian; Dersch, Petra; Lenz, Georg; Koeffler, H Phillip; Berdel, Wolfgang E; Bäumer, Sebastian.
Affiliation
  • Bäumer N; Department of Medicine A, Hematology/Oncology, University of Münster, Münster, Germany.
  • Tiemann J; Department of Medicine A, Hematology/Oncology, University of Münster, Münster, Germany.
  • Scheller A; Department of Medicine A, Hematology/Oncology, University of Münster, Münster, Germany.
  • Meyer T; Institute of Infectiology-Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany.
  • Wittmann L; Department of Medicine A, Hematology/Oncology, University of Münster, Münster, Germany.
  • Suburu MEG; Institute of Inorganic and Analytical Chemistry, University of Münster, Münster, Germany.
  • Greune L; Institute of Infectiology-Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany.
  • Peipp M; Division of Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-University, Kiel, Germany.
  • Kellmann N; Department of Medicine A, Hematology/Oncology, University of Münster, Münster, Germany.
  • Gumnior A; Department of Medicine A, Hematology/Oncology, University of Münster, Münster, Germany.
  • Brand C; Department of Medicine A, Hematology/Oncology, University of Münster, Münster, Germany.
  • Hartmann W; Gerhard-Domagk Institute for Pathology, University of Münster, Münster, Germany.
  • Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
  • Müller-Tidow C; Department of Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Neri D; Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
  • Strassert CA; Institute of Inorganic and Analytical Chemistry, University of Münster, Münster, Germany.
  • Rüter C; Institute of Infectiology-Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany.
  • Dersch P; Institute of Infectiology-Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany.
  • Lenz G; Department of Medicine A, Hematology/Oncology, University of Münster, Münster, Germany.
  • Koeffler HP; Cedars Sinai Medical Center, University of California, Los Angeles, CA, USA.
  • Berdel WE; Department of Medicine A, Hematology/Oncology, University of Münster, Münster, Germany.
  • Bäumer S; Department of Medicine A, Hematology/Oncology, University of Münster, Münster, Germany. baumers@uni-muenster.de.
Oncogene ; 41(15): 2210-2224, 2022 04.
Article in En | MEDLINE | ID: mdl-35220407

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Oncogene Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Oncogene Year: 2022 Document type: Article